相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Management of Hyperglycemia, Dyslipidemia, and Albuminuria in Patients With Diabetes and CKD: A Systematic Review for a KDOQI Clinical Practice Guideline
Yelena Slinin et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Effects of HbA1c and weight reduction on blood pressure in patients with type 2 diabetes mellitus treated with exenatide
S. Paul et al.
DIABETES OBESITY & METABOLISM (2012)
One-year safety, tolerability and efficacy of vildagliptin in patients with type 2 diabetes and moderate or severe renal impairment
W. Kothny et al.
DIABETES OBESITY & METABOLISM (2012)
Repaglinide A Review of Its Use in Type 2 Diabetes Mellitus
Lesley J. Scott
DRUGS (2012)
Protein-Restricted Diets Plus Keto/Amino Acids - A Valid Therapeutic Approach for Chronic Kidney Disease Patients
Michel Aparicio et al.
JOURNAL OF RENAL NUTRITION (2012)
LINAGLIPTIN AS ADD-ON THERAPY FOR TYPE 2 DIABETES - AN OVERVIEW
D. X. Brown et al.
DRUGS OF TODAY (2012)
Peroxisome proliferator-activated receptor-γ agonists repress epithelial sodium channel expression in the kidney
Emily Borsting et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Caloric restriction: powerful protection for the aging heart and vasculature
Edward P. Weiss et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Saxagliptin
David W. Boulton et al.
CLINICAL PHARMACOKINETICS (2011)
Antidiabetic Agents in Patients with Chronic Kidney Disease and End-Stage Renal Disease on Dialysis: Metabolism and Clinical Practice
Masanori Abe et al.
CURRENT DRUG METABOLISM (2011)
Pramlintide and the treatment of diabetes: a review of the data since its introduction
Lisa M. Younk et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Incretin-based therapy: a powerful and promising weapon in the treatment of type 2 diabetes mellitus
Chrysi Koliaki et al.
Diabetes Therapy (2011)
Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies
Yoon Kong Loke et al.
BRITISH MEDICAL JOURNAL (2011)
Pharmacokinetics of dipeptidylpeptidase-4 inhibitors
A. J. Scheen
DIABETES OBESITY & METABOLISM (2010)
Limitations of metformin use in patients with kidney disease: are they warranted?
K. P. Vasisht et al.
DIABETES OBESITY & METABOLISM (2010)
Clinical effectiveness and safety evaluation of long-term pioglitazone treatment for erythropoietin responsiveness and insulin resistance in type 2 diabetic patients on hemodialysis
Masanori Abe et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients
Neal Mittman et al.
KIDNEY INTERNATIONAL (2010)
Thiazolidinediones, cardiovascular disease and cardiovascular mortality: translating research into action for diabetes (TRIAD)
Dori Bilik et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Glycemic Control and Burnt-Out Diabetes in ESRD
Csaba P. Kovesdy et al.
SEMINARS IN DIALYSIS (2010)
Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide
Lisbeth V. Jacobsen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Glycemic Control and Cardiovascular Events in Diabetic Hemodialysis Patients
Christiane Drechsler et al.
CIRCULATION (2009)
Impact of fear of insulin or fear of injection on treatment outcomes of patients with diabetes
Alex Z. Fu et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes New results from the ADVANCE trial
Sophia Zoungas et al.
DIABETES CARE (2009)
Pharmacokinetics of the Dipeptidyl Peptidase 4 Inhibitor Saxagliptin in Rats, Dogs, and Monkeys and Clinical Projections
Aberra Fura et al.
DRUG METABOLISM AND DISPOSITION (2009)
Rosiglitazone Is Associated with Mortality in Chronic Hemodialysis Patients
Sylvia P. B. Ramirez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Hypoglycemia in Diabetic Patients Undergoing Chronic Hemodialysis
Chiao-Yin Sun et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2009)
Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency
J. C. N. Chan et al.
DIABETES OBESITY & METABOLISM (2008)
Safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of BI 1356, an inhibitor of dipeptidyl peptidase 4, in healthy male volunteers
S. Huettner et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Effect of renal impairment on the pharmacokinetics of exenatide
Helle Linnebjerg et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Biology of incretins: GLP-1 and GIP
Laurie L. Baggio et al.
GASTROENTEROLOGY (2007)
Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: Effect of anemia and erythropoietin injection
Masaaki Inaba et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Steven E. Kahn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Practical review of oral antihyperglycemic agents for type 2 diabetes mellitus
Renee Rae Koski
DIABETES EDUCATOR (2006)
Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes
Gary A. Herman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Peroxisome proliferator-activated receptor gamma agonists in renal disease
Pedro Iglesias et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective
RR Holman
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Investigation of exenatide elimination and its in vivo and in vitro degradation
Kathrin Copley et al.
CURRENT DRUG METABOLISM (2006)
Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes
F Fehse et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Rosiglitazone reduces insulin requirement and C-reactive protein levels in type 2 diabetic patients receiving peritoneal dialysis
TYH Wong et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Coadministration of gemfibrozil and itraconazole has only a minor effect on the pharmacokinetics of the CYP2C9 and CYP3A4 substrate nateglinide
M Niemi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Type 2 diabetes - Therapy with dipeptidyl peptidase IV inhibitors
HU Demuth et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Drug therapy: Thiazolidinediones
H Yki-Jarvinen
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Thiazolidinedione use, fluid retention, and congestive heart failure - A consensus statement from the American Heart Association and American Diabetes Association
RW Nesto et al.
CIRCULATION (2003)
The pharmacokinetics of pioglitazone in patients with impaired renal function
K Budde et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Metformin: An update
D Kirpichnikov et al.
ANNALS OF INTERNAL MEDICINE (2002)
Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease
K Shinohara et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Oral antihyperglycemic therapy for type 2 diabetes - Scientific review
SE Inzucchi
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema nucleus of the solitary tract (AP/NTS) lesioned rats
TA Lutz et al.
INTERNATIONAL JOURNAL OF OBESITY (2001)
Glycemic control is a predictor of survival for diabetic patients on hemodialysis
T Morioka et al.
DIABETES CARE (2001)
Effect of acarbose on insulin sensitivity in elderly patients with diabetes
GS Meneilly et al.
DIABETES CARE (2000)
Drug-induced desensitization of insulinotropic actions of sulfonylureas
AJ Ball et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
